Skip to content
MedGenome US is now rebranded as Signios Bio – same team, renewed identity.
Login
Contact
Sequencing Services
Menu Toggle
Single Cell Sequencing
Spatial Transcriptomics
RNA Sequencing
Immune Profiling
Proteomics
Long Read Sequencing
Premade Library Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Oncology Panel Sequencing
Epigenomics
Certified Service Provider
Multiomics Solutions
Menu Toggle
Multiomics – Academics and Research Institutes
Multiomics – Pharmaceutical & Biotechnology Companies
Multiomics – Clinical & Diagnostics Laboratories
Multiomics – Contract Research Organizations
Bioinformatics Solutions
Resources
Menu Toggle
Documents
Publications
Blog
Posters & Videos
FAQs
Company
Menu Toggle
About
News & Events
Careers
Contact
Main Menu
Sequencing Services
Menu Toggle
Single Cell Sequencing
Spatial Transcriptomics
RNA Sequencing
Immune Profiling
Proteomics
Long Read Sequencing
Premade Library Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Oncology Panel Sequencing
Epigenomics
Certified Service Provider
Multiomics Solutions
Menu Toggle
Multiomics – Academics and Research Institutes
Multiomics – Pharmaceutical & Biotechnology Companies
Multiomics – Clinical & Diagnostics Laboratories
Multiomics – Contract Research Organizations
Bioinformatics Solutions
Resources
Menu Toggle
Documents
Publications
Blog
Posters & Videos
Company
Menu Toggle
About
News & Events
Careers
Contact
Login
Press Releases
2016
2017
2018
2019
2020
2023
2024
2025
Signios Bio and Illumina Announce Winners of the Illumina–Signios Bio Proteomics Grant Program
October 28, 2025
Multiomics: A 360° View into Biology and Medicine
July 4, 2025
How will AI affect cancer treatment and diagnosis?
June 25, 2025
Signios Bio and Illumina Announce Grant to Maximize Discovery Power with Industry’s Largest NGS-Based Proteomics Panel
May 19, 2025
Signios Bio Launches with AI-Driven Bioinformatics and Advanced Multiomics Platform to Power the Future of Precision Medicine and Drug Discovery
April 10, 2025
MedGenome Appoints Industry Veterans Felix Olale, M.D., Ph.D., as CEO and Jennifer Rose as Chief Commercial Officer to Lead U.S. Expansion
October 23, 2024
MedGenome boosts omic insights capabilities as the first commercial provider in the San Francisco Bay Area of California to bring PacBio Revio in-house with full service capability
July 18, 2024
MedGenome announces de novo Genome Assembly and Annotation Grant winners for 2024
May 2, 2024
MedGenome appoints Martin Dewhurst as Chairman of Advisory Board
November 28, 2023
MedGenome, in collaboration with PacBio, announces a de novo genome assembly and annotation grant to empower non-model organism research
November 21, 2023
Load More
